1. Home
  2. ENOV vs GAM Comparison

ENOV vs GAM Comparison

Compare ENOV & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • GAM
  • Stock Information
  • Founded
  • ENOV 1995
  • GAM 1927
  • Country
  • ENOV United States
  • GAM United States
  • Employees
  • ENOV N/A
  • GAM N/A
  • Industry
  • ENOV Fluid Controls
  • GAM Investment Managers
  • Sector
  • ENOV Industrials
  • GAM Finance
  • Exchange
  • ENOV Nasdaq
  • GAM Nasdaq
  • Market Cap
  • ENOV 1.6B
  • GAM 1.4B
  • IPO Year
  • ENOV 2008
  • GAM N/A
  • Fundamental
  • Price
  • ENOV $32.14
  • GAM $60.42
  • Analyst Decision
  • ENOV Strong Buy
  • GAM
  • Analyst Count
  • ENOV 6
  • GAM 0
  • Target Price
  • ENOV $51.00
  • GAM N/A
  • AVG Volume (30 Days)
  • ENOV 1.0M
  • GAM 20.1K
  • Earning Date
  • ENOV 11-05-2025
  • GAM 01-01-0001
  • Dividend Yield
  • ENOV N/A
  • GAM 5.74%
  • EPS Growth
  • ENOV N/A
  • GAM N/A
  • EPS
  • ENOV N/A
  • GAM 11.67
  • Revenue
  • ENOV $2,189,576,000.00
  • GAM N/A
  • Revenue This Year
  • ENOV $9.13
  • GAM N/A
  • Revenue Next Year
  • ENOV $6.39
  • GAM N/A
  • P/E Ratio
  • ENOV N/A
  • GAM $3.95
  • Revenue Growth
  • ENOV 14.40
  • GAM N/A
  • 52 Week Low
  • ENOV $25.47
  • GAM $37.32
  • 52 Week High
  • ENOV $49.83
  • GAM $46.48
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 62.91
  • GAM 71.51
  • Support Level
  • ENOV $30.00
  • GAM $59.63
  • Resistance Level
  • ENOV $31.76
  • GAM $60.78
  • Average True Range (ATR)
  • ENOV 1.04
  • GAM 0.60
  • MACD
  • ENOV 0.21
  • GAM 0.01
  • Stochastic Oscillator
  • ENOV 82.68
  • GAM 82.11

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About GAM General American Investors Inc.

General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.

Share on Social Networks: